Black History

PRESS ROOM: Pfizer and the National Newspaper Publishers Association Collaborate to Raise Awareness of Sickle Cell Disease and Need for Improved Patient Care

Media Contacts: Steven Danehy 212-733-1538 Steven.Danehy@pfizer.com Claudette Perry 212-588-8764 Ext. 2 cperry@nnpa.org Collaboration Aims to Educate on the Importance of Clinical Trials in Developing Potential New Sickle Cell Disease Therapies NEW YORK, NY, March 24, 2017 – Pfizer Inc. (NYSE:PFE) and the National Newspaper Publishers Read More

Health

For Diabetics, a New Insulin Inhaler Could Replace Shots as Early as 2014

[Business Week] The long promise of insulin that diabetics can inhale appears to be moving closer to the market. An inhalable insulin powder called Afrezza showed positive results for controlling diabetes in a late-stage clinical trial, the drug’s maker, MannKind (MNKD), reported today. Pharmaceutical companies have been Read More

Health

Rare Mutation Ignites Race for Cholesterol Drug

[New York Times] She was a 32-year-old aerobics instructor from a Dallas suburb — healthy, college educated, with two young children. Nothing out of the ordinary, except one thing. Her cholesterol was astoundingly low. Her low-density lipoprotein, or LDL, the form that promotes heart disease, Read More